Evidence map›Paper›PMID 34282697›Full record

SynthesisAnnals of medicine2021

Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis.

Yanhui Gu, Ying Zhang, Qian Wen, Yao Ouyang, Yongchun Shen, He Yu, Chun Wan, Jing Zhu, Fuqiang Wen

Abstract readMeta-Analysis
In one paragraph

Synthesis in Annals of medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Diagnostic performance of FEVChronic respiratory disease
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Current Progress of COPD Early Detection: Key Points and Novel Strategies.International journal of chronic obstructive pulmonary disease · 2023
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yanhui GuDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
Ying ZhangDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
Qian WenHealth Management Center, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yao OuyangDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Yongchun ShenDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
He YuDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
Chun WanDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
Jing ZhuDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
Fuqiang WenDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to validate the chronic obstructive pulmonary disease (COPD) Population Screener (COPD-PS) questionnaire as a screening tool in a cohort of Chinese subjects who underwent a health examination, and to summarise its overall performance through a meta-analysis. We enrolled 997 subjects aged ≥40 years who underwent a health examination, both lung function and COPD-PS data were collected. The screening performance of COPD-PS was evaluated with a receiver operating characteristic (ROC) curve analysis, using the area under the curve (AUC) to assess the screening accuracy. A standard diagnostic meta-analysis was used to summarise the screening performance of COPD-PS for COPD. Of the 997 subjects, 157 were identified as having COPD. The COPD-PS score was significantly higher in COPD patients than controls (5.03 ± 5.11 vs. 2.72 ± 1.80,

Indexed as

AdultAgedAged, 80 and overFemaleHumansMaleMass ScreeningMiddle AgedPulmonary Disease, Chronic ObstructiveReproducibility of ResultsROC CurveSensitivity and SpecificitySpirometrySurveys and QuestionnairesChronic obstructive pulmonary diseasechronic obstructive pulmonary disease population screenermeta-analysisscreening

Identifiers

PMID34282697
PMCPMC8293944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.